A MAM-targeting therapeutic peptide restores autophagy homeostasis and ameliorates atherosclerosis
Theranostics · 2026
DOI: 10.7150/thno.132357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Jungmin Ha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Genomics Leader Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, 50 Yonsei-ro…. Hauptthemen laut MEDLINE: Atherosclerosis, Autophagy, Peptides. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Genomics Leader Research Laboratory, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
- Department of Materials Science and Engineering, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 03722, Republic of Korea.
Zitieren
APA
Ha, J., Ko, M., Lim, Y. B., & Kwon, H. J. (2026). A MAM-targeting therapeutic peptide restores autophagy homeostasis and ameliorates atherosclerosis. Theranostics. https://doi.org/10.7150/thno.132357
Vancouver
Ha J, Ko M, Lim YB, Kwon HJ. A MAM-targeting therapeutic peptide restores autophagy homeostasis and ameliorates atherosclerosis. Theranostics. 2026. doi:10.7150/thno.132357
BibTeX
@article{Ha2026,
author = {Ha, Jungmin and Ko, Minjeong and Lim, Yong-Beom and Kwon, Ho Jeong},
title = {A MAM-targeting therapeutic peptide restores autophagy homeostasis and ameliorates atherosclerosis},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.132357}
}
EUVIMED